← All patents

US20170360725A1

Fkbp52-specific androgen receptor inhibitor, mjc13, for use in treating breast …

University of Texas System

Abstract

Embodiments of the current invention include methods and compositions for treating breast cancer by administering an effective amount of MJC13 to a subject in need thereof.

University
University of Texas System
Assignee
The Board Of Regents Of The University Of Texas System
Inventor
Marc B. Cox
Priority date
June 15, 2016
Filing date
June 15, 2017
Publication date
December 21, 2017
Language
en
Metadata fetched
August 29, 2026 00:25